Recent investment activity

KANDO id: 125013

Corporate information

Registration country

Company type

Fund managed by California Technology Ventures

Fund terms

Funding rounds

Profile Country


Investment activity status
Active investor

Selected investments

Displaying 1 - 14 of 14
Profile Country Date Funding
Ablexis LLC Biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery. N/A
Agile Materials and Technologies Inc Telecommunications equipment company focused on the design and fabrication of tunable integrated components for wireless communications applications. N/A
Ceregene Inc Biotechnology company focused on the development and commercialization of gene therapies for the treatment of neurological disorders. Series C
DolphinSearch Inc Provider of electronic document discovery solutions. N/A
Insert Therapeutics Inc Medical research company that uses nanobiotechnology specializing in therapeutic agents that are conjugated, to facilitate and enhance drug delivery N/A
MindCruiser Inc Leading developer of software infrastructure solutions for professional associations and corporate communities. N/A
Moss Software Inc Provider of CRM software products with solutions that resolved its customers' sales force automation challenges and better managed their sales cycles. N/A
PhotoThera Inc Medical device company focusing on the $20 billion soft tissue injury market. N/A
SupplyEdge Inc Provider of software solutions for the electronic component for supply chains. N/A
SurgRx Inc N/A
Turbine Inc American computer game developer that pioneers 3D massively multiplayer online role-playing games (MMORPGs). N/A
Vivant Medical Inc Developer of microwave ablation technology for the minimally invasive treatment of benign and cancerous soft tissue tumors. N/A
AngioScore Inc Developer, maker, and seller of leading edge tools for endovascular therapy. Series B
Spine Wave Inc Medical device company focused on degenerative disc disease, vertebral compression fractures, and nucleus replacement. Series C

Current team

Past employees

Selected Products / Customers

Financials